Seroprevalence of Toxoplasma gondii among HIV Patients in Jahrom, Southern Iran
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Toxoplasma gondii is an important opportunistic agent especially in immunocompromised hosts and can cause significant morbidity and mortality. Hence, detection and monitoring of anti-Toxoplasma antibodies are of a great interest in HIV-infected patients. A study on the prevalence of toxoplasmosis and associated risk factors was carried out among HIV-infected patients in Jahrom, southern Iran. The prevalence of anti-Toxoplasma IgG antibodies was 21.1% in HIV-infected patients by ELISA. PCR was performed on all of the samples, and 1 of the blood samples was positively detected. Among the HIV patients, anti-Toxoplasma IgG antibodies were significantly higher in age group of 30-39 years old (P=0.05). The seroprevalence of toxoplasmosis in patients with CD4+<100 cells/μl was 33.3% that was significantly higher than the other groups (P=0.042) with or without IgG antibodies. The CD4+ count mean of seropositive patients was lower than that of seronegative patients. The seroprevalence of toxoplasmosis in patients with highly active antiretroviral therapy was significantly less than patients without therapy (P=0.02). In conclusion, this study showed low seroprevalence of latent toxoplasmosis among HIV-infected patients in the region and confirmed the need for intensifying prevention efforts among this high-risk population and also the risk of toxoplasmosis reactivation which could be important among this population.
Abstract
Toxoplasma gondii is an important opportunistic agent especially in immunocompromised hosts and can cause significant morbidity and mortality. Hence, detection and monitoring of anti-Toxoplasma antibodies are of a great interest in HIV-infected patients. A study on the prevalence of toxoplasmosis and associated risk factors was carried out among HIV-infected patients in Jahrom, southern Iran. The prevalence of anti-Toxoplasma IgG antibodies was 21.1% in HIV-infected patients by ELISA. PCR was performed on all of the samples, and 1 of the blood samples was positively detected. Among the HIV patients, anti-Toxoplasma IgG antibodies were significantly higher in age group of 30-39 years old (P=0.05). The seroprevalence of toxoplasmosis in patients with CD4+<100 cells/μl was 33.3% that was significantly higher than the other groups (P=0.042) with or without IgG antibodies. The CD4+ count mean of seropositive patients was lower than that of seronegative patients. The seroprevalence of toxoplasmosis in patients with highly active antiretroviral therapy was significantly less than patients without therapy (P=0.02). In conclusion, this study showed low seroprevalence of latent toxoplasmosis among HIV-infected patients in the region and confirmed the need for intensifying prevention efforts among this high-risk population and also the risk of toxoplasmosis reactivation which could be important among this population.
참고문헌 (20)
- Grant IH, "Toxoplasma gondii serology in HIV-infected patients : the development of central nervous system toxoplasmosis in AIDS", AIDS, 4, pp.519~522 (1990)
- Mamidi A, "Central nervous system infections in individuals with HIV-1 infection", J Neurovirol, 8, pp.158~167 (2002)
- Machala L, "Antibody response of HIV-infected patients to latent, cerebral and recently acquired toxoplasmosis", Eur J Clin Microbiol Infect Dis, 28, pp.179~182 (2009)
- Daryani A, "Seroprevalence of Toxoplasma gondii in the Iranian general population : a systematic review and meta-analysis", Acta Trop, 137, pp.185~194 (2014)
- Jones JL, "Toxoplasmosis-related knowledge and practices among pregnant women in the United States", Infect Dis Obstet Gynecol, 11, pp.139~145 (2003)
- Ruiz-Fons F, "Seroprevalence of six reproductive pathogens in European wild boar(Sus scrofa)from Spain : the effect on wild boar female reproductive performance", Theriogenology, 65, pp.731~743 (2006)
- 송경주, "Seroprevalence of toxoplasmosis in Korean pregnant women", The Korean Journal of Parasitology, 43(2), pp.1~10 (2005), 대한기생충학ㆍ열대의학회
- Hari KR, "Reduced risk of Toxoplasma encephalitis in HIV-infected patients-a prospective study from Gauteng, South Africa", Int J STD AIDS, 18, pp.555~558 (2007)
- Fan CK, "Seroprevalence of Toxoplasma gondii infection among inhabitants in the Democratic Republic of São Tome and Principe", Trans R Soc Trop Med Hyg, 101, pp.1157~1158 (2007)
- Jones CD, "Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of T. gondii in aqueous humor", Invest Ophthalmol Vis Sci, 41, pp.634~644 (2000)
- Davarpanah M, "Toxoplasmosis in HIV", AIDS patients in Shiraz, southern Iran, 2007, pp.9, 22~27
- Rostami A, "Frequency of Toxoplasma gondii in HIV positive patients from West of Iran by ELISA and PCR", Iran J Parasitol, 9, pp.474~481 (2014)
- Alavi SM, "Comparative study on Toxoplasma serology among HIV positive and HIV negative illicit drug users in Ahvaz, Iran", Caspian J Intern Med, 4, pp.781~784 (2013)
- Quoqing Shen, "Seroprevalence of Toxoplasma gondii Infection among HIV", AIDS Patients in Eastern China, 2016, pp.54(1), 93~96[DOI]
- Nissapatorn V, "Toxoplasmosis in HIV", AIDS patients : a current situation, 2004, pp.57, 160~165
- Kistiah K, "Seroprevalence of Toxoplasma gondii infection in HIV-positive and HIV-negative subjects in Gauteng, South Africa", South Afr J Epidemiol Infect, 26, pp.225~228 (2011)
- Lindström Kaddu-Mulindwa DH, "Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda", Acta Trop, 100, pp.218~222 (2006)
- Zangerle R Allerberger F, "High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii", Med Microbiol Immunol, 180, pp.59~66 (1991)
- Osunkalu VO, "Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital", HIV, 2011, pp.3, 101~105
- Bennett JE, "Principles and Practice of Infectious Diseases", pp.310~315 (2014), Elsevier Saunders